Startseite Evaluation of Accuracy and Uncertainty of ELISA Assays for the Determination of Interleukin-4, Interleukin-5, Interferon-γ and Tumor Necrosis Factor-α
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Evaluation of Accuracy and Uncertainty of ELISA Assays for the Determination of Interleukin-4, Interleukin-5, Interferon-γ and Tumor Necrosis Factor-α

  • Lone Borg , Jesper Kristiansen , Jytte M. Christensen , Karen F. Jepsen und Lars K. Poulsen
Veröffentlicht/Copyright: 1. Juni 2005
Veröffentlichen auch Sie bei De Gruyter Brill
Clinical Chemistry and Laboratory Medicine (CCLM)
Aus der Zeitschrift Band 40 Heft 5

Abstract

The comparison of analytical results calls for validation of the assays used, i.e. for the documentation of accuracy (trueness and precision), linearity and specificity. In addition, there is a growing demand for evaluation and documentation of traceability and uncertainty of analytical results. However, models for establishing the traceability and uncertainty of immunoassay results are lacking.

Sandwich enzyme-linked immunosorbent assays (ELISAs) were developed for determination of the human cytokines interleukin-4 (IL-4), interleukin-5 (IL-5), interferon-γ (IFN-γ) and tumor necrosis factor-α(TNF-α. The accuracy of each of the assays was evaluated in the ranges of 1–15 μg/l (IL-4), 0.001–1 μg/l (IL-5), 0.5–2.5 μg/l (IFN-γ) and 0.14–2.2 μg/l (TNF Other evaluated performance characteristics were the limit of detection (LOD), immunological specificity, and robustness. Traceability was ensured by the use of World Health Organization International Standards (WHO IS). An uncertainty budget, which combined the contribution from all known uncertainty components, was established for each cytokine ELISA.

The between-run relative analytical standard deviation (RsDA) of the assessed ELISAs was found to be in the range of 11–18%, except for IL-5 where RSDA increased at decreasing concentrations. The LOD was 0.12 μg/l, 0.0077 μg/l, 0.0069 μg/l and 0.0063 μg/l for IL-4, IL-5, IFN-γ and TNF-α respectively. Traceability to the WHO IS was established for each of the cytokines. The combined relative standard uncertainty (uresult/Cresult) was 28%, 22–62%, 28% and 24% for the IL-4, IL-5, IFN-γ and TNF-α results, respectively. The major contributions to uncertainty came from the relative analytical standard deviation and from the uncertainty of the mass concentration of the WHO IS. The uncertainty of the WHO IS was not stated in the accompanying certificate and was evaluated by other means.

The largest sources of uncertainty were located outside our laboratory. This means that the possibilities to improve the reliability of the results produced by the ELISAs are very limited. The task of evaluating measurement uncertainty would be much easier if producers of international reference standards reported the uncertainty of the value of standards. The model for evaluating uncertainty presented in this paper is applicable to other types of assays and to most analytical methods.

:
Published Online: 2005-06-01
Published in Print: 2002-06-06

Copyright © 2002 by Walter de Gruyter GmbH & Co. KG

Artikel in diesem Heft

  1. XV Latin American Congress of Clinical Biochemistry, Florianópolis, Brazil, 1–5 July 2001
  2. A Method to Detect the G894T Polymorphism of the NOS3 Gene. Clinical Validation in Familial Hypercholesterolemia
  3. Increasing the Sensitivity of Single-Strand Conformation Polymorphism Analysis of the LDLR Gene Mutations in Brazilian Patients with Familial Hypercholesterolemia
  4. Hormone Replacement Therapy in Postmenopausal Women and Its Effects on Plasma Lipid Levels
  5. The Effect of N-Acetylcysteine Supplementation upon Viral Load, CD4, CD8, Total Lymphocyte Count and Hematocrit in Individuals Undergoing Antiretroviral Treatment
  6. An Evaluation of Antiretroviral Therapy Associated with α-Tocopherol Supplementation in HIV-infected Patients
  7. Effects of Re-education in Eating Habits and Physical Activity on the Lipid Profile of Obese Teenagers
  8. Myeloperoxidase-mediated Protein Oxidation: Its Possible Biological Functions
  9. Novel Haptoglobin Insertion/Deletion Polymorphism Is Associated with the Lipid Profile and C-Reactive Protein (CRP) Concentration
  10. Apolipoprotein E2/E2 Genotype in Combination with Mutations in the LDL Receptor Gene Causes Type III Hyperlipoproteinemia
  11. High-Sensitivity Human Thyroglobulin (hTG) Immunoradiometric Assay in the Follow-up of Patients with Differentiated Thyroid Cancer
  12. Tissue Transglutaminase-Serology Markers for Coeliac Disease
  13. Serum Adenosine Deaminase and Cytidine Deaminase Activities in Patients with Systemic Lupus Erythematosus
  14. Effects of Oral N-Acetylcysteine on Plasma Homocysteine and Whole Blood Glutathione Levels in Healthy, Non-pregnant Women
  15. Evaluating Sequential Values Using Time-adjusted Biological Variation
  16. High-dose Methylprednisolone Therapy in Multiple Sclerosis Increases Serum Uric Acid Levels
  17. Evaluation of Accuracy and Uncertainty of ELISA Assays for the Determination of Interleukin-4, Interleukin-5, Interferon-γ and Tumor Necrosis Factor-α
  18. Development of Immunoturbidimetric Assays for Fourteen Human Serum Proteins on the Hitachi 912™
  19. Multicenter Evaluation of a Fully Mechanized Soluble Transferrin Receptor Assay on the Hitachi and Cobas Integra Analyzers. The Determination of Reference Ranges
  20. IFCC News: May/June 2002
  21. Meetings and Awards
Heruntergeladen am 21.10.2025 von https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2002.089/html?lang=de
Button zum nach oben scrollen